Neumora Therapeutics, Inc.'s total assets for Q1 2025 were $256.75M, a decrease of -19.00% from the previous quarter. NMRA total liabilities were $28.38M for the fiscal quarter, a -5.10% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.